Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood.
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.
Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
Exceptional, naturally occurring HIV-1 control: Insight into a functional cure.
Sustained aviraemia despite anti-retroviral therapy non-adherence in male children following in utero hiv transmission.
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study.
Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.
Targeting Viral Transcription for HIV Cure Strategies.
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.